Medigus (Omer, Israel) received FDA clearance for the latest version of its minimally invasive GERD (gastroesophageal reflux disease) treatment system. The MUSE, known as the SRS System in its previous incarnation, allows a physician to perform an anterior fundoplication using one instrument that includes a stapler, video camera, and ultrasonic sights that help with alignment.
Fundoplication normally involves opening the abdominal wall or less invasively with laparoscopic instruments. The MUSE system allows the procedure to be done endoscopically, restoring the functionality of the esophageal valve with just a few staples and in less than an hour. This allows patients that would otherwise not be great candidates for surgery to receive appropriate therapy and may become a standard for fundoplication procedures in general.
New features in the Muse system according to the announcement:
The new MUSE™ System is easier to use, with an improved graphical user interface. The next generation system leverages LED illumination and advancements in one of the world’s smallest video cameras to achieve enhanced, digital resolution and an improved field of view. In addition, the new system has a more compact console, motorized stapler ejection mechanism, software controls ensuring safe operation, and an alignment pin mechanism to ensure precise alignment prior to staple delivery. These new features complement existing elements such as ultrasound guidance and easy handling, enabling single operator surgery. The surgical endoscope remains disposable, ensuring patient safety.
Product page: Medigus MUSE…